bluebird bio, Inc. Insider Trading for October 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in bluebird bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in bluebird bio, Inc. for October 2017.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 24 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 145.26 | 3,700 | 537,455 | 255,359 | 259.1 K to 255.4 K (-1.43 %) |
Oct 24 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 145.02 | 3,350 | 485,813 | 259,059 | 262.4 K to 259.1 K (-1.28 %) |
Oct 19 2017 | BLUE | bluebird bio, Inc. | Leschly Nick | President and CEO | Sell | S | 145.05 | 10,823 | 1,569,840 | 262,409 | 273.2 K to 262.4 K (-3.96 %) |
Oct 11 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Option Exercise | M | 5.50 | 4,900 | 26,952 | 62,585 | |
Oct 11 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 131.80 | 500 | 65,900 | 27,305 | 27.8 K to 27.3 K (-1.80 %) |
Oct 11 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 130.27 | 1,600 | 208,425 | 27,805 | 29.4 K to 27.8 K (-5.44 %) |
Oct 11 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Sell | S | 129.43 | 2,800 | 362,399 | 29,405 | 32.2 K to 29.4 K (-8.69 %) |
Oct 11 2017 | BLUE | bluebird bio, Inc. | Walsh Jeffrey T. | Chief Financial | Buy | M | 5.50 | 4,900 | 26,952 | 32,205 | 27.3 K to 32.2 K (+17.95 %) |
Oct 04 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Option Exercise | M | 50.51 | 1,250 | 63,138 | 24,500 | |
Oct 04 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 132.15 | 50 | 6,608 | 28,484 | 28.5 K to 28.5 K (-0.18 %) |
Oct 04 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Sell | S | 131.82 | 2,200 | 289,995 | 28,534 | 30.7 K to 28.5 K (-7.16 %) |
Oct 04 2017 | BLUE | bluebird bio, Inc. | Gregory Philip D | Chief Scientific Of ... | Buy | M | 50.51 | 1,250 | 63,138 | 30,734 | 29.5 K to 30.7 K (+4.24 %) |
Oct 04 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Option Exercise | M | 5.50 | 4,000 | 22,002 | 87,151 | |
Oct 04 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 132.20 | 200 | 26,440 | 15,977 | 16.2 K to 16 K (-1.24 %) |
Oct 04 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 131.75 | 2,459 | 323,979 | 16,177 | 18.6 K to 16.2 K (-13.19 %) |
Oct 04 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Sell | S | 130.37 | 1,341 | 174,830 | 18,636 | 20 K to 18.6 K (-6.71 %) |
Oct 04 2017 | BLUE | bluebird bio, Inc. | Davidson David | Chief Medical Offic ... | Buy | M | 5.50 | 4,000 | 22,002 | 19,977 | 16 K to 20 K (+25.04 %) |